USA / U-Turn as Biden Pledges Support for Waiver on COVID-19 Vaccine IP
In a shock move, Joe Biden’s administration looks set to support a waiver on intellectual property (IP)…
Patrick Burton |
Editor
Patrick is an editor at PharmaBoardroom, writing and editing stories on all things healthcare and the life sciences. The holder of a Master's Degree in International Relations, Patrick has contributed to over 40 country reports and is a fluent Mandarin speaker.
Articles: Patrick Burton
APAC / Diagnostics in the Post-COVID Era
COVID-19 has pushed diagnostics to the forefront of healthcare conversations across the world. Here, three leading…
Global / Innovative Pharma Doubles Down on IP with New Pact
On World Intellectual Property (IP) Day 2021, the innovative biopharmaceutical industry came together to launch a…
Korea / Samsung Bioepis Goes Down Under; Blockchain-Based Vaccine Certificates; The First Korean Blockbuster?
The latest news from Korean pharma, including how Korea can put the infrastructure in place to develop a homegrown…
MENA / Egypt Opens 'Pharma City'; Koçak’s COVID Vaccine Enters Phase I; Abu Dhabi Strengthens Hub Status
The latest Middle East and North Africa (MENA) pharma, including Egypt’s opening of the largest “pharmaceutical…
Switzerland / MSD AVP on Recent Zurich R&D Investment
In February 2020, US giant MSD announced the launch of a new site in Zurich specialising in R&D, data…
APAC / The Challenges of Regulatory Convergence in Medtech
Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue,…
Pharma Logistics Under COVID / Partnerships, Digitalisation & New Customer Service Models
The vital importance of robust supply chains and distribution networks has been foregrounded over the past year as…
China / Antitrust Threat to Pharma; June BioNTech Vaccine Approval; EpimAb IPO; CanSino Inhaled Vaccine Trials
The latest China pharma news, including the upcoming first domestic approval for a foreign COVID-19 vaccine in…
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
Switzerland / A Sea Change in the Biotech Start-up Ecosystem?
In a recent conversation with PharmaBoardroom, Michael Sidler of Redalpine Venture Partners, a venture capital (VC)…
Singapore / Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…